Insider Trades82 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Sell | VNRX | Rodney Gerard Rootsaert | Secretary | 3,948 | $0.19 | $4.2M | -97.90% | +1.44% | $750.12 | -1.42% | — | — |
| Mar 17, 2026 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 5,251 | $0.19 | $4.2M | -97.90% | +1.44% | $997.69 | -1.56% | — | — |
| Mar 17, 2026 | Sell | VNRX | Jacob Vincent Micallef | Chief Scientific Officer | 5,310 | $0.19 | $4.2M | -97.90% | +1.44% | $1.0K | -0.92% | — | — |
| Mar 17, 2026 | Sell | VNRX | Nicholas Plummer | GC - Volition Diagnostics | 7,003 | $0.19 | $4.2M | -97.90% | +1.44% | $1.3K | -1.69% | — | — |
| Mar 1, 2026 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 2,283 | $0.21 | $4.2M | -97.90% | +1.44% | $486.279 | -0.67% | — | — |
| Mar 1, 2026 | Sell | VNRX | Rodney Gerard Rootsaert | Secretary | 3,321 | $0.21 | $4.2M | -97.90% | +1.44% | $707.373 | -1.18% | — | — |
| Mar 1, 2026 | Sell | VNRX | Nicholas Plummer | GC - Volition Diagnostics | 5,867 | $0.21 | $4.2M | -97.90% | +1.44% | $1.2K | -1.40% | — | — |
| Feb 1, 2026 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 2,010 | $0.28 | $4.2M | -97.90% | +1.44% | $572.85 | -1.05% | — | — |
| Feb 1, 2026 | Sell | VNRX | Rodney Gerard Rootsaert | Secretary | 3,196 | $0.28 | $4.2M | -97.90% | +1.44% | $910.86 | -1.93% | — | — |
| Feb 1, 2026 | Sell | VNRX | Nicholas Plummer | GC - Volition Diagnostics | 5,647 | $0.28 | $4.2M | -97.90% | +1.44% | $1.6K | -2.36% | — | — |
| Nov 17, 2025 | Buy | VNRX | Cameron John Reynolds | President and CEO | 20,000 | $0.35 | $4.2M | -97.90% | +1.44% | $7.0K | +0.79% | — | — |
| Nov 1, 2025 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 1,753 | $0.43 | $4.2M | -97.90% | +1.44% | $760.802 | -1.13% | — | — |
| Nov 1, 2025 | Sell | VNRX | Rodney Gerard Rootsaert | Secretary | 3,197 | $0.43 | $4.2M | -97.90% | +1.44% | $1.4K | -2.28% | — | — |
| Nov 1, 2025 | Sell | VNRX | Andrew Retter | Chief Medical Officer | 4,588 | $0.43 | $4.2M | -97.90% | +1.44% | $2.0K | -3.04% | — | — |
| Nov 1, 2025 | Sell | VNRX | Salvatore Thomas Butera | CEO - Volition Veterinary | 4,648 | $0.43 | $4.2M | -97.90% | +1.44% | $2.0K | -1.42% | — | — |
| Nov 1, 2025 | Sell | VNRX | Nicholas Plummer | GC - Volition Diagnostics | 5,647 | $0.43 | $4.2M | -97.90% | +1.44% | $2.5K | -2.83% | — | — |
| Oct 14, 2025 | Buy | VNRX | Cameron John Reynolds | President and CEO | 110,000 | $0.51 | $4.2M | -97.90% | +1.44% | $56.1K | +4.34% | — | — |
| Oct 4, 2025 | Sell | VNRX | Rodney Gerard Rootsaert | Secretary | 4,620 | $0.65 | $4.2M | -97.90% | +1.44% | $3.0K | -3.18% | — | — |
| Oct 4, 2025 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 5,389 | $0.65 | $4.2M | -97.90% | +1.44% | $3.5K | -3.35% | — | — |
| Oct 4, 2025 | Sell | VNRX | Salvatore Thomas Butera | CEO - Volition Veterinary | 5,834 | $0.65 | $4.2M | -97.90% | +1.44% | $3.8K | -1.76% | — | — |
| Oct 4, 2025 | Sell | VNRX | Jacob Vincent Micallef | Chief Scientific Officer | 5,850 | $0.65 | $4.2M | -97.90% | +1.44% | $3.8K | -1.47% | — | — |
| Oct 4, 2025 | Sell | VNRX | Ann-Louise Batchelor | Group Chief Marketing Officer | 6,110 | $0.65 | $4.2M | -97.90% | +1.44% | $4.0K | -3.96% | — | — |
| Oct 4, 2025 | Sell | VNRX | Nicholas Plummer | GC - Volition Diagnostics | 8,146 | $0.65 | $4.2M | -97.90% | +1.44% | $5.3K | -3.92% | — | — |
| Oct 4, 2025 | Sell | VNRX | Gaetan Michel | Chief Operating Officer | 12,333 | $0.65 | $4.2M | -97.90% | +1.44% | $8.0K | -4.58% | — | — |
| Sep 28, 2025 | Sell | VNRX | Rodney Gerard Rootsaert | Secretary | 4,158 | $0.60 | $4.2M | -97.90% | +1.44% | $2.5K | -2.79% | — | — |
| Sep 28, 2025 | Sell | VNRX | Salvatore Thomas Butera | CEO - Volition Veterinary | 5,230 | $0.60 | $4.2M | -97.90% | +1.44% | $3.2K | -1.55% | — | — |
| Sep 28, 2025 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 5,503 | $0.60 | $4.2M | -97.90% | +1.44% | $3.3K | -3.31% | — | — |
| Sep 28, 2025 | Sell | VNRX | Jacob Vincent Micallef | Chief Scientific Officer | 5,568 | $0.60 | $4.2M | -97.90% | +1.44% | $3.4K | -1.38% | — | — |
| Sep 28, 2025 | Sell | VNRX | Ann-Louise Batchelor | Group Chief Marketing Officer | 5,604 | $0.60 | $4.2M | -97.90% | +1.44% | $3.4K | -3.50% | — | — |
| Sep 28, 2025 | Sell | VNRX | Gaetan Michel | Chief Operating Officer | 11,362 | $0.60 | $4.2M | -97.90% | +1.44% | $6.9K | -2.99% | — | — |
| Sep 12, 2025 | Buy | VNRX | Cameron John Reynolds | President and CEO | 15,000 | $0.66 | $4.2M | -97.90% | +1.44% | $9.9K | +0.57% | — | — |
| Aug 5, 2025 | Buy | VNRX | Cameron John Reynolds | President and CEO | 78,125 | $0.64 | $4.2M | -97.90% | +1.44% | $50.0K | +3.09% | — | — |
| Aug 1, 2025 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 2,766 | $0.64 | $4.2M | -97.90% | +1.44% | $1.8K | -1.73% | — | — |
| Aug 1, 2025 | Sell | VNRX | Rodney Gerard Rootsaert | Secretary | 4,279 | $0.64 | $4.2M | -97.90% | +1.44% | $2.7K | -3.09% | — | — |
| Aug 1, 2025 | Sell | VNRX | Nicholas Plummer | GC - Volition Diagnostics | 4,451 | $0.64 | $4.2M | -97.90% | +1.44% | $2.8K | -2.36% | — | — |
| Aug 1, 2025 | Sell | VNRX | Andrew Retter | Chief Medical Officer | 6,142 | $0.64 | $4.2M | -97.90% | +1.44% | $3.9K | -4.46% | — | — |
| Aug 1, 2025 | Sell | VNRX | Salvatore Thomas Butera | CEO - Volition Veterinary | 6,393 | $0.64 | $4.2M | -97.90% | +1.44% | $4.1K | -2.06% | — | — |
| Aug 1, 2025 | Sell | VNRX | Ann-Louise Batchelor | Group Chief Marketing Officer | 8,620 | $0.64 | $4.2M | -97.90% | +1.44% | $5.5K | -6.11% | — | — |
| Jul 1, 2025 | Sell | VNRX | Rodney Gerard Rootsaert | Secretary | 3,066 | $0.77 | $4.2M | -97.90% | +1.44% | $2.4K | -2.17% | — | — |
| Jul 1, 2025 | Sell | VNRX | Andrew Retter | Chief Medical Officer | 4,401 | $0.77 | $4.2M | -97.90% | +1.44% | $3.4K | -3.10% | — | — |
| Jul 1, 2025 | Sell | VNRX | Salvatore Thomas Butera | CEO - Volition Veterinary | 4,462 | $0.77 | $4.2M | -97.90% | +1.44% | $3.4K | -1.42% | — | — |
| Jul 1, 2025 | Sell | VNRX | Nicholas Plummer | GC - Volition Diagnostics | 5,417 | $0.77 | $4.2M | -97.90% | +1.44% | $4.2K | -2.80% | — | — |
| Jul 1, 2025 | Sell | VNRX | Ann-Louise Batchelor | Group Chief Marketing Officer | 6,177 | $0.77 | $4.2M | -97.90% | +1.44% | $4.7K | -4.19% | — | — |
| Jun 12, 2025 | Buy | VNRX | Cameron John Reynolds | President and CEO | 12,500 | $0.59 | $4.2M | -97.90% | +1.44% | $7.4K | +0.54% | — | — |
| Jun 1, 2025 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 1,996 | $0.77 | $4.2M | -97.90% | +1.44% | $1.5K | -1.24% | — | — |
| Jun 1, 2025 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 4,234 | $0.50 | $4.2M | -97.90% | +1.44% | $2.1K | -2.56% | — | — |
| Jun 1, 2025 | Sell | VNRX | Andrew Retter | Chief Medical Officer | 4,598 | $0.50 | $4.2M | -97.90% | +1.44% | $2.3K | -3.13% | — | — |
| Jun 1, 2025 | Sell | VNRX | Rodney Gerard Rootsaert | Secretary | 6,408 | $0.50 | $4.2M | -97.90% | +1.44% | $3.2K | -4.34% | — | — |
| Jun 1, 2025 | Sell | VNRX | Gaetan Michel | Chief Operating Officer | 7,835 | $0.50 | $4.2M | -97.90% | +1.44% | $3.9K | -2.02% | — | — |
| Jun 1, 2025 | Sell | VNRX | Salvatore Thomas Butera | CEO, Volition Veterinary | 11,683 | $0.50 | $4.2M | -97.90% | +1.44% | $5.9K | -3.58% | — | — |
| Jun 1, 2025 | Sell | VNRX | Jacob Vincent Micallef | Chief Scientific Officer | 21,526 | $0.50 | $4.2M | -97.90% | +1.44% | $10.8K | -5.05% | — | — |
| May 19, 2025 | Buy | VNRX | Cameron John Reynolds | President and CEO | 20,000 | $0.44 | $4.2M | -97.90% | +1.44% | $8.7K | +0.87% | — | — |
| May 19, 2025 | Buy | VNRX | Jacob Vincent Micallef | Chief Scientific Officer | 50,000 | $0.43 | $4.2M | -97.90% | +1.44% | $21.5K | +13.30% | — | — |
| May 1, 2025 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 3,698 | $0.49 | $4.2M | -97.90% | +1.44% | $1.8K | -2.27% | — | — |
| May 1, 2025 | Sell | VNRX | Rodney Gerard Rootsaert | Secretary | 5,453 | $0.49 | $4.2M | -97.90% | +1.44% | $2.7K | -3.81% | — | — |
| May 1, 2025 | Sell | VNRX | Gaetan Michel | Chief Operating Officer | 6,844 | $0.49 | $4.2M | -97.90% | +1.44% | $3.3K | -1.73% | — | — |
| May 1, 2025 | Sell | VNRX | Salvatore Thomas Butera | CEO, Volition Veterinary | 10,205 | $0.49 | $4.2M | -97.90% | +1.44% | $5.0K | -3.26% | — | — |
| May 1, 2025 | Sell | VNRX | Jacob Vincent Micallef | Chief Scientific Officer | 18,319 | $0.49 | $4.2M | -97.90% | +1.44% | $8.9K | -4.65% | — | — |
| Mar 26, 2025 | Buy | VNRX | Cameron John Reynolds | President and CEO | 181,818 | $0.55 | $4.2M | -97.90% | +1.44% | $100.0K | +8.59% | — | — |
| Dec 9, 2024 | Buy | VNRX | Jacob Vincent Micallef | Chief Scientific Officer | 43,691 | $0.57 | $4.2M | -97.90% | +1.44% | $25.0K | +12.46% | — | — |
| Dec 9, 2024 | Buy | VNRX | Cameron John Reynolds | President and CEO | 139,811 | $0.57 | $4.2M | -97.90% | +1.44% | $80.0K | +7.07% | — | — |
| Oct 4, 2024 | Sell | VNRX | Rodney Gerard Rootsaert | Secretary | 4,620 | $0.88 | $4.2M | -97.90% | +1.44% | $4.1K | -3.49% | — | — |
| Oct 4, 2024 | Sell | VNRX | Jacob Vincent Micallef | Chief Scientific Officer | 5,200 | $0.88 | $4.2M | -97.90% | +1.44% | $4.6K | -1.46% | — | — |
| Oct 4, 2024 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 5,433 | $0.88 | $4.2M | -97.90% | +1.44% | $4.8K | -3.44% | — | — |
| Oct 4, 2024 | Sell | VNRX | Salvatore Thomas Butera | CEO, Volition Veterinary | 5,834 | $0.88 | $4.2M | -97.90% | +1.44% | $5.2K | -2.06% | — | — |
| Oct 4, 2024 | Sell | VNRX | Ann-Louise Batchelor | Group Chief Marketing Officer | 6,110 | $0.88 | $4.2M | -97.90% | +1.44% | $5.4K | -5.67% | — | — |
| Oct 4, 2024 | Sell | VNRX | Nicholas Plummer | GC, Volition Diagnostics | 8,146 | $0.88 | $4.2M | -97.90% | +1.44% | $7.2K | -5.04% | — | — |
| Sep 28, 2024 | Sell | VNRX | Nicholas Plummer | GC Volition Diagnostics | 1,497 | $0.58 | $4.2M | -97.90% | +1.44% | $865.266 | -0.92% | — | — |
| Sep 28, 2024 | Sell | VNRX | Rodney Gerard Rootsaert | Secretary | 4,158 | $0.58 | $4.2M | -97.90% | +1.44% | $2.4K | -3.04% | — | — |
| Sep 28, 2024 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 4,824 | $0.58 | $4.2M | -97.90% | +1.44% | $2.8K | -2.97% | — | — |
| Sep 28, 2024 | Sell | VNRX | Jacob Vincent Micallef | Chief Scientific Officer | 4,950 | $0.58 | $4.2M | -97.90% | +1.44% | $2.9K | -1.37% | — | — |
| Sep 28, 2024 | Sell | VNRX | Salvatore Thomas Butera | CEO Volition Veterinary | 5,230 | $0.58 | $4.2M | -97.90% | +1.44% | $3.0K | -1.82% | — | — |
| Sep 28, 2024 | Sell | VNRX | Ann-Louise Batchelor | Group Chief Marketing Officer | 5,604 | $0.58 | $4.2M | -97.90% | +1.44% | $3.2K | -4.95% | — | — |
| May 1, 2024 | Sell | VNRX | Salvatore Thomas Butera | CEO, Volition Veterinary | 15,504 | $0.87 | $4.2M | -97.90% | +1.44% | $13.5K | -7.21% | — | — |
| Dec 18, 2023 | Buy | VNRX | Salvatore Thomas Butera | CEO - Volition Veterinary | 10,000 | $0.83 | $4.2M | -97.90% | +1.44% | $8.3K | +11.19% | — | — |
| Dec 15, 2023 | Buy | VNRX | Salvatore Thomas Butera | CEO - Volition Veterinary | 10,000 | $0.77 | $4.2M | -97.90% | +1.44% | $7.7K | +12.60% | — | — |
| Dec 13, 2023 | Buy | VNRX | Rodney Gerard Rootsaert | Secretary | 10,000 | $0.60 | $4.2M | -97.90% | +1.44% | $6.0K | +14.57% | — | — |
| Dec 8, 2023 | Buy | VNRX | Cameron John Reynolds | President and CEO | 10,000 | $0.67 | $4.2M | -97.90% | +1.44% | $6.7K | +0.59% | — | — |
| Nov 16, 2023 | Buy | VNRX | Salvatore Thomas Butera | CEO - Volition Veterinary | 10,000 | $0.81 | $4.2M | -97.90% | +1.44% | $8.1K | +14.42% | — | — |
| Oct 4, 2023 | Sell | VNRX | Gael Forterre | Chief Commercial Officer | 5,527 | $0.68 | $4.2M | -97.90% | +1.44% | $3.7K | -5.13% | — | — |
| Oct 4, 2023 | Sell | VNRX | Salvatore Thomas Butera | CEO - Volition Veterinary | 5,834 | $0.68 | $4.2M | -97.90% | +1.44% | $3.9K | -3.16% | — | — |
| Oct 4, 2023 | Sell | VNRX | Gaetan Michel | Chief Operating Officer | 15,412 | $0.68 | $4.2M | -97.90% | +1.44% | $10.4K | -7.24% | — | — |